Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.4.2681

Cervical Cancer : Is Vaccination Necessary in India?  

Farhath, Seema (Bharathiar University)
Vijaya, P.P. (Department of Biotechnology, Mohamed Sathak College of Arts and Science)
Mumtaj, P. (Department of Biotechnology, Mohamed Sathak College of Arts and Science)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.4, 2013 , pp. 2681-2684 More about this Journal
Abstract
In India, cervical cancer is the most common woman-related cancer, followed by breast cancer. The rate of cervical cancer in India is fourth worldwide. Two vaccines, Gardasil and Cervarix, both targeting HPV-16 and 18 which account for 70% of invasive cervical carcinomas, are licensed in the United States and numerous countries worldwide. Both vaccine formulations have shown excellent efficacy with minimal toxicity in active female population but numerous questions arise in vaccinating like cost effectiveness, lack of proven efficacy against other HPV strains, social acceptance of HPV vaccination and other ethical issues. The main objective of this study is to emphasis the advantages and disadvantages of the vaccination in India.
Keywords
Cervix cancer; Gardasil; Cervarix; vaccine; HPV;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ambika Satija Cervical Cancer In India (2010). sancd.org/uploads/pdf/cervical_cancer.pdf
2 Braaten KP, Laufer MR (2008). Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. Rev Obstet Gynecol, 1, 2-10.
3 Cervical cancer-National Cancer Institute (2010). www.cancer. gov/cancertopics/factsheet/cancer-advances-in-focus/ cervical.
4 Department Of Health And Human Services (2011). Centers for Disease Control and Prevention. www.cdc.gov/std/hpv and www.cdc.gov/vaccines
5 Cervarix. Fact sheet: HPV vaccine for protection against cervical cancer. (2010) http://www. ncbi.nlm.nih.gov/pubmedhealth/PMH0005142/
6 FDA (US Food and Drug Administration) (2009). Information pertaining to labeling revision for Gardasil-Rockville: FDA.
7 Ferenczy A, Franco E (2001). Cervical cancer screening beyond the year 2000. Lancet Oncol, 2, 27-32.   DOI   ScienceOn
8 Gauravi AM, Sharmila AP, Surendra SS (2011). An overview of prevention and early detection of cervical cancers. Indian J Med Paediatr Oncol, 32, 125-32.   DOI   ScienceOn
9 Herrero R (2009). Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. J Infect Dis, 199, 919-22.   DOI   ScienceOn
10 Kawana K, Yasugi T, Taketani Y (2009). Human papillomavirus vaccines: Current issues and future. Indian J Med Res, 130, 341-7.
11 Munoz N, Castellsague X, de Gonzalez AB, Gissmann L (2006). HPV in the etiology of human cancer. Vaccine, 24, 1-10   DOI   ScienceOn
12 National Comprehensive Cancer Network (2011). NCCN Practice Guidelines in Oncology: Cervical Cancer Screening. v 1.
13 Noller KL (2007). Intraepithelial neoplasia of the lower genital tract (cervix, vulva): Etiology, screening, diagnostic techniques, management. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier; chap 28.
14 Sankaranarayanan R, Ferlay J (2006). Worldwide burden of gynecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol, 20, 207-25.   DOI   ScienceOn
15 Schiffman M, Wacholder S (2009). From India to the world-a better way to prevent cervical cancer. N Engl J Med, 360, 1453-5.   DOI   ScienceOn
16 Singh N (2005). HPV and Cervical cancer-prospects for prevention through vaccination. Indian J Med Paediatr Oncol, 26, 20-3.
17 Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW (2010). Cancer screening in the United States, a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin, 60, 99-119.   DOI   ScienceOn
18 Tovar JM, Bazaldua OV, Vargas L, Reile E (2008). Human papillomavirus, cervical cancer, and the vaccines. Postgrad Med, 120, 79-84.   DOI   ScienceOn
19 Winer RL, Hughes JP, Feng Q, et al (2006). Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med, 354, 2645-54.   DOI   ScienceOn
20 World Health Organization, authors. (2009) Weekly Epidemiological Record. Geneva; World Health Organization; Human papillomavirus vaccines. http://www.who.int/wer/2009/wer8415.pdf.